6DFT image
Deposition Date 2018-05-15
Release Date 2018-08-08
Last Version Date 2023-10-11
Entry Detail
PDB ID:
6DFT
Keywords:
Title:
Trypanosoma brucei deoxyhypusine synthase
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.50 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Deoxyhypusine synthase
Gene (Uniprot):DHSc
Chain IDs:A, C, E, G, I, K
Chain Length:461
Number of Molecules:6
Biological Source:Trypanosoma brucei
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Deoxyhypusine synthase regulatory subunit
Gene (Uniprot):DHSp
Chain IDs:B, D, F, H, J, L
Chain Length:342
Number of Molecules:6
Biological Source:Trypanosoma brucei
Primary Citation
Trypanosomatid Deoxyhypusine Synthase Activity Is Dependent on Shared Active-Site Complementation between Pseudoenzyme Paralogs.
Structure 26 1499 1512.e5 (2018)
PMID: 30197036 DOI: 10.1016/j.str.2018.07.012

Abstact

Trypanosoma brucei is a neglected tropical disease endemic to Africa. The polyamine spermidine is essential for post-translational hypusine modification of eukaryotic initiation factor 5A (eIF5A), which is catalyzed by deoxyhypusine synthase (TbDHS). In trypanosomatids, deoxyhypusine synthase (DHS) activity is dependent on heterotetramer formation between two paralogs, DHSc and DHSp, both with minimal activity on their own due to missing catalytic residues. We determined the X-ray structure of TbDHS showing a single functional shared active site is formed at the DHSc/DHSp heterodimer interface, with deficiencies in one subunit complemented by the other. Each heterodimer contains two NAD+ binding sites, one housed in the functional catalytic site and the second bound in a remnant dead site that lacks key catalytic residues. Functional analysis of these sites by site-directed mutagenesis identified long-range contributions to the catalytic site from the dead site. Differences between trypanosomatid and human DHS that could be exploited for drug discovery were identified.

Legend

Protein

Chemical

Disease

Primary Citation of related structures